MedTrace Logo

Reduction of Metabolic Acidosis in Patients With Chronic Kidney Disease in Stage 4 and 5

NCT05784389 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-03-29

No results posted yet for this study

Summary

This clinical trial aims to investigate and test the effect of an acid/base diet in chronic kidney disease (CKD) patients, CKD stage 4 and 5. The trial is guided by the hypothesis that an acid/base diet will reduce the degree of acidosis and simultaneously reduce the need for bicarbonate supplements.

Conditions

Interventions

OTHER

Low PRAL

Two weeks on a low PRAL diet compared to 2 week free living

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • Nordsjaellands Hospital

    lead OTHER

Principal Investigators

  • Lisbet Brandi, Doctor Med · Nordsjaellands Hospital

  • Jens R Andersen, As. prof. · University of Copenhagen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-27
Primary Completion
2023-06-20
Completion
2023-11-20

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05784389 on ClinicalTrials.gov